135 related articles for article (PubMed ID: 17452063)
1. Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation.
Ortar G; Cascio MG; Moriello AS; Camalli M; Morera E; Nalli M; Di Marzo V
Eur J Med Chem; 2008 Jan; 43(1):62-72. PubMed ID: 17452063
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms.
Maione S; Morera E; Marabese I; Ligresti A; Luongo L; Ortar G; Di Marzo V
Br J Pharmacol; 2008 Nov; 155(5):775-82. PubMed ID: 18660824
[TBL] [Abstract][Full Text] [Related]
3. Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
Fowler CJ; Ghafouri N
Pharmacol Res; 2008 Jul; 58(1):72-6. PubMed ID: 18675915
[TBL] [Abstract][Full Text] [Related]
4. The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.
Alexander JP; Cravatt BF
J Am Chem Soc; 2006 Aug; 128(30):9699-704. PubMed ID: 16866524
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
6. New tetrazole-based selective anandamide uptake inhibitors.
Ortar G; Schiano Moriello A; Cascio MG; De Petrocellis L; Ligresti A; Morera E; Nalli M; Di Marzo V
Bioorg Med Chem Lett; 2008 May; 18(9):2820-4. PubMed ID: 18424134
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
Fowler CJ
Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
[TBL] [Abstract][Full Text] [Related]
9. Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.
De Lago E; Gustafsson SB; Fernández-Ruiz J; Nilsson J; Jacobsson SO; Fowler CJ
J Neurochem; 2006 Oct; 99(2):677-88. PubMed ID: 16899063
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase.
Cisneros JA; Vandevoorde S; Ortega-Gutiérrez S; Paris C; Fowler CJ; López-Rodríguez ML
J Med Chem; 2007 Oct; 50(20):5012-23. PubMed ID: 17764163
[TBL] [Abstract][Full Text] [Related]
12. FAAH and anandamide: is 2-AG really the odd one out?
Di Marzo V; Maccarrone M
Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
[TBL] [Abstract][Full Text] [Related]
14. Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis.
Pulgar VM; Yamaleyeva LM; Varagic J; McGee CM; Bader M; Dechend R; Howlett AC; Brosnihan KB
Hypertension; 2014 Sep; 64(3):619-25. PubMed ID: 24935942
[TBL] [Abstract][Full Text] [Related]
15. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
Pertwee RG
Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
[TBL] [Abstract][Full Text] [Related]
16. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS.
Williams J; Wood J; Pandarinathan L; Karanian DA; Bahr BA; Vouros P; Makriyannis A
Anal Chem; 2007 Aug; 79(15):5582-93. PubMed ID: 17600384
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.
Thors L; Eriksson J; Fowler CJ
Br J Pharmacol; 2007 Nov; 152(5):744-50. PubMed ID: 17676056
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
[TBL] [Abstract][Full Text] [Related]
19. Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro.
Vandevoorde S; Jonsson KO; Labar G; Persson E; Lambert DM; Fowler CJ
Br J Pharmacol; 2007 Jan; 150(2):186-91. PubMed ID: 17143303
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism.
Ortar G; Bisogno T; Ligresti A; Morera E; Nalli M; Di Marzo V
J Med Chem; 2008 Nov; 51(21):6970-9. PubMed ID: 18831576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
